Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery

Hepatocellular carcinoma (HCC) is the sixth most common form of cancer worldwide. Although surgical treatments have an acceptable cure rate, tumor recurrence is still a challenging issue. In this meta-analysis, we investigated whether statins prevent HCC recurrence following liver surgery.

Bibliographic Details

Main Authors:	Khajeh, Elias (Author) , Dooghaie Moghadam, Arash (Author) , Eslami, Pegah (Author) , Ali-Hasan-Al-Saegh, Sadeq (Author) , Ramouz, Ali (Author) , Shafiei, Saeed (Author) , Ghamarnejad, Omid (Author) , Abbasi Dezfouli, Sepehr (Author) , Rupp, Christian (Author) , Springfeld, Christoph (Author) , Carvalho, Carlos (Author) , Probst, Pascal (Author) , Mousavizadeh, Seyed Mostafa (Author) , Mehrabi, Arianeb (Author)
Format:	Article (Journal)
Language:	English
Published:	21 January 2022
In:	BMC cancer Year: 2022, Volume: 22, Pages: 1-9
ISSN:	1471-2407
DOI:	10.1186/s12885-022-09192-1
Online Access:	Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12885-022-09192-1
Author Notes:	Elias Khajeh, Arash Dooghaie Moghadam, Pegah Eslami, Sadeq Ali-Hasan-Al-Saegh, Ali Ramouz, Saeed Shafiei, Omid Ghamarnejad, Sepehr Abbasi Dezfouli, Christian Rupp, Christoph Springfeld, Carlos Carvalho, Pascal Probst, Seyed Mostafa Mousavizadeh and Arianeb Mehrabi